Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
3348 articles
Articles
SS Innovations Expands Robotic Cardiac Surgery Program to HCG Hospital in Ahmedabad
SS Innovations International has launched a robotic cardiac surgery program at HCG Hospital in Ahmedabad, marking another step in the global adoption of its SSi Mantra system.
September 24, 2026Read the full article
Quantum BioPharma's Lucid-MS Cleared by FDA for Phase 2 Multiple Sclerosis Trial
The FDA's approval of Quantum BioPharma's IND application for Lucid-MS allows the company to begin Phase 2 testing of its multiple sclerosis candidate, potentially offering a novel treatment approach for the disease.
September 24, 2026Read the full article
Why Cancer Care Is Becoming More Complex Despite Advances
As cancer care evolves with personalized immunotherapies, the complexity of treatment is increasing, making each patient's journey more unique and challenging to manage.
September 24, 2026Read the full article
German Sports Nutrition Brand TNT Brings Its Story to U.S. Retail Buyers at ECRM
German sports nutrition brand TNT used the ECRM Vitamin, Weight Management & Sports Nutrition Session to introduce its established product portfolio to U.S. retail buyers, signaling a step beyond e-commerce into broader American retail distribution.
September 24, 2026Read the full article
Quantum BioPharma's Lucid-MS Targets Unmet Need in Multiple Sclerosis
Quantum BioPharma is advancing Lucid-MS, a drug candidate that aims to inhibit demyelination in multiple sclerosis by targeting an enzyme called peptidyl arginine deiminase 2, addressing a significant unmet need in progressive forms of the disease.
September 23, 2026Read the full article
American Heart Association Awards $1.1M in Grants to Boost CPR Training and Cardiac Emergency Plans in 30 States
The American Heart Association has granted over $1.1 million to implement Cardiac Emergency Response Plans at 185 sites across 30 states, aiming to improve cardiac arrest survival through community preparedness.
September 23, 2026Read the full article
Annovis Bio Taps Weave Bio's AI Platform to Accelerate Buntanetap NDA Preparation for Alzheimer's and Parkinson's
Annovis Bio collaborates with Weave Bio to use AI for drafting and managing its buntanetap NDA, aiming to streamline regulatory submission while maintaining rigorous oversight.
September 23, 2026Read the full article
Kairos Pharma to Present KROS-101 Research at Discovery on Target Conference
Kairos Pharma will present its KROS-101 drug candidate targeting GITR at a major cancer drug discovery conference, highlighting its strategy to overcome therapy resistance.
September 23, 2026Read the full article
BFCH Signs Binding LOI with NEXT10 to Build Expanded Health, Wellness and Longevity Platform
BitFrontier Capital Holdings (BFCH) has entered a binding letter of intent with NEXT10 that will bring revenue-producing assets and a significant ownership stake into BFCH, aiming to expand its health, wellness, and longevity platform.
September 23, 2026Read the full article
Helus Pharma Shareholders Approve Name Change and Re-elect Directors at Annual Meeting
Helus Pharma (NASDAQ: HELP) held its annual and special meeting on Sept. 22, 2026, where shareholders approved a legal name change from Cybin Inc. to Helus Pharma Inc. and elected eight directors, marking a strategic shift toward commercialization.
September 23, 2026Read the full article
NeuroThera Expands U.S. Patent Portfolio with Psychedelic-Combination Therapies
NeuroThera Labs has broadened its U.S. patent portfolio through a collaboration with Clearmind Medicine, covering novel combinations of LSD, ketamine, and ibogaine with its proprietary PEA technology for potential mental health and substance use disorder treatments.
September 23, 2026Read the full article
NFL and American Heart Association Award Super Bowl Tickets and $50,000 in PE Equipment for CPR Education
Five students won Super Bowl LXI tickets and five schools received $10,000 each for physical activity equipment as part of an American Heart Association and NFL Foundation initiative to promote Hands-Only CPR education in schools.
September 23, 2026Read the full article
Boston BioLife to Co-Present Translational Longevity Summit at Harvard, Marking 11 Years of Bench-to-Bedside Mission
Boston BioLife will co-present the Translational Longevity Summit at Harvard's Enterprise Research Campus from October 7-11, 2026, bringing together cross-sector leaders to address how longevity science can be responsibly translated into clinical care.
September 23, 2026Read the full article
Simple Waist-to-Height Ratio Emerges as Reliable Global Screening Tool for Pediatric Liver Disease, Study Finds
A new international study shows that waist-to-height ratio (WHtR) with a threshold of 0.48 effectively screens for metabolic dysfunction-associated steatotic liver disease (MASLD) in children across diverse ethnic and genetic backgrounds, potentially simplifying early detection worldwide.
September 23, 2026Read the full article
Certified Health Care Advisor Launches Online Testing Through WebCE
The Certified Health Care Advisor designation now offers online testing through WebCE, expanding access to certification and continuing education for insurance and financial planning professionals.
September 23, 2026Read the full article
SunKnowledge Prepares Hospitals for FY 2027 Medicare Inpatient Billing Changes
SunKnowledge is helping hospitals adapt their revenue-cycle operations to the FY 2027 Medicare inpatient payment changes, which include a 2.3% rate increase but also heightened documentation and coding requirements.
September 23, 2026Read the full article
Roth Capital Partners to Host 5th Annual Healthcare Opportunities Conference in New York
Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, in New York City, connecting over 30 public healthcare companies with institutional investors.
September 22, 2026Read the full article
Survey Reveals Health Insurance Fails to Protect Many Americans from Medical Debt
A new Commonwealth Fund survey shows that a significant number of insured U.S. adults still face medical debt, highlighting gaps in health coverage and the need for reform.
September 22, 2026Read the full article
Lantern Pharma's LP-284 Patent Allowance Extends Blood Cancer Treatment Protection to 2042
Lantern Pharma received a USPTO Notice of Allowance for a patent covering LP-284 in mantle cell lymphoma, double-hit lymphoma, and other blood cancers, potentially extending market exclusivity into 2042 and strengthening its oncology pipeline.
September 22, 2026Read the full article
AI Maverick Intel Adds Healthcare Veteran to Board as It Pursues HEAL Access Acquisition
AI Maverick Intel appoints Dr. Wayne Young to its board and advances its acquisition of HEAL Access Canada, signaling a strategic shift toward AI-enabled healthcare solutions.
September 22, 2026Read the full article
American Heart Association and American Headache Society Unite to Fund Migraine-Heart Research
The American Heart Association and American Headache Society have co-funded a $200,000 Innovative Project Award to study the link between migraines and cardiovascular health, with three additional projects funded by the AHA.
September 22, 2026Read the full article